Paper Chase

Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first.

Cell metabolism
Nov 05, 2019 30 (5) 847-849
Vol. 30, Issue 5, Medline Page 847-849

The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure.

Authors: Bhatt DL, Verma S, Braunwald E
Abstract:
In a randomized trial of patients with heart failure and reduced ejection fraction, the SGLT2 inhibitor dapagliflozin markedly reduced mortality and worsening heart failure (McMurray et al., 2019). Remarkably, these benefits seemed to be similar in people with and without diabetes. These data usher in a new paradigm in the treatment of heart failure.